These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 11576081
1. Increased plasma eotaxin in atopic dermatitis and acute urticaria in infants and children. Hossny E, Aboul-Magd M, Bakr S. Allergy; 2001 Oct; 56(10):996-1002. PubMed ID: 11576081 [Abstract] [Full Text] [Related]
2. Elevated plasma eotaxin levels in patients with acute asthma. Lilly CM, Woodruff PG, Camargo CA, Nakamura H, Drazen JM, Nadel ES, Hanrahan JP. J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 1):786-90. PubMed ID: 10518822 [Abstract] [Full Text] [Related]
3. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis. Park CW, Lee BH, Han HJ, Lee CH, Ahn HK. Br J Dermatol; 2005 Jun; 152(6):1173-81. PubMed ID: 15948978 [Abstract] [Full Text] [Related]
4. Elevation of plasma eotaxin levels in children with food allergy. Matsuura H, Ishiguro A, Abe H, Mamada Y, Suzuki T, Kohda K, Shimbo T. Nihon Rinsho Meneki Gakkai Kaishi; 2009 Jun; 32(3):180-5. PubMed ID: 19564714 [Abstract] [Full Text] [Related]
5. Presence of high contents of thymus and activation-regulated chemokine in platelets and elevated plasma levels of thymus and activation-regulated chemokine and macrophage-derived chemokine in patients with atopic dermatitis. Fujisawa T, Fujisawa R, Kato Y, Nakayama T, Morita A, Katsumata H, Nishimori H, Iguchi K, Kamiya H, Gray PW, Chantry D, Suzuki R, Yoshie O. J Allergy Clin Immunol; 2002 Jul; 110(1):139-46. PubMed ID: 12110833 [Abstract] [Full Text] [Related]
6. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczyk A. Allergy; 2005 May; 60(5):685-8. PubMed ID: 15813816 [Abstract] [Full Text] [Related]
7. Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. Taha RA, Minshall EM, Leung DY, Boguniewicz M, Luster A, Muro S, Toda M, Hamid QA. J Allergy Clin Immunol; 2000 May; 105(5):1002-7. PubMed ID: 10808183 [Abstract] [Full Text] [Related]
8. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis. Kagami S, Kakinuma T, Saeki H, Tsunemi Y, Fujita H, Nakamura K, Takekoshi T, Kishimoto M, Mitsui H, Torii H, Komine M, Asahina A, Tamaki K. Clin Exp Immunol; 2003 Nov; 134(2):309-13. PubMed ID: 14616792 [Abstract] [Full Text] [Related]
9. [Serum levels of NO products, IL-8, RANTES and eotaxin in infantile patients with atopic dermatitis]. Kurita F. Arerugi; 2000 Jul; 49(7):577-84. PubMed ID: 10944824 [Abstract] [Full Text] [Related]
10. Serum mucosa-associated epithelial chemokine (MEC/CCL28) in atopic dermatitis: a specific marker for severity. Ezzat MH, Sallam MA, Shaheen KY. Int J Dermatol; 2009 Aug; 48(8):822-9. PubMed ID: 19659860 [Abstract] [Full Text] [Related]
11. Development of a sensitive enzyme-linked immunosorbent assay for eotaxin and measurement of its levels in human blood. Morita A, Shimosako K, Kikuoka S, Taniguchi Y, Kitaura M, Sasakura K, Tamaki M, Tsuji T, Teraoka H, Yoshie O, Nakajima T, Hirai K. J Immunol Methods; 1999 Jun 24; 226(1-2):159-67. PubMed ID: 10410981 [Abstract] [Full Text] [Related]
12. Circulating interleukin 16 (IL-16) in children with atopic/eczema dermatitis syndrome (AEDS): a novel serological marker of disease activity. Frezzolini A, Paradisi M, Zaffiro A, Provini A, Cadoni S, Ruffelli M, De Pità O. Allergy; 2002 Sep 24; 57(9):815-20. PubMed ID: 12169178 [Abstract] [Full Text] [Related]
13. Enhanced expression of eotaxin and CCR3 in atopic dermatitis. Yawalkar N, Uguccioni M, Schärer J, Braunwalder J, Karlen S, Dewald B, Braathen LR, Baggiolini M. J Invest Dermatol; 1999 Jul 24; 113(1):43-8. PubMed ID: 10417617 [Abstract] [Full Text] [Related]
14. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES). Ying S, Robinson DS, Meng Q, Barata LT, McEuen AR, Buckley MG, Walls AF, Askenase PW, Kay AB. J Immunol; 1999 Oct 01; 163(7):3976-84. PubMed ID: 10491000 [Abstract] [Full Text] [Related]
15. Expression of eotaxin, an eosinophil-selective chemokine, parallels eosinophil accumulation in the vesiculobullous stage of incontinentia pigmenti. Jean-Baptiste S, O'Toole EA, Chen M, Guitart J, Paller A, Chan LS. Clin Exp Immunol; 2002 Mar 01; 127(3):470-8. PubMed ID: 11966763 [Abstract] [Full Text] [Related]
16. Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines. Shahabuddin S, Ponath P, Schleimer RP. J Immunol; 2000 Apr 01; 164(7):3847-54. PubMed ID: 10725746 [Abstract] [Full Text] [Related]
19. Serum eotaxin levels in patients with chronic spontaneous urticaria. Tedeschi A, Asero R, Lorini M, Marzano AV, Cugno M. Eur Ann Allergy Clin Immunol; 2012 Oct 01; 44(5):188-92. PubMed ID: 23156066 [Abstract] [Full Text] [Related]
20. Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co-localization of eotaxin mRNA to bronchial epithelial and endothelial cells. Ying S, Robinson DS, Meng Q, Rottman J, Kennedy R, Ringler DJ, Mackay CR, Daugherty BL, Springer MS, Durham SR, Williams TJ, Kay AB. Eur J Immunol; 1997 Dec 01; 27(12):3507-16. PubMed ID: 9464841 [Abstract] [Full Text] [Related] Page: [Next] [New Search]